These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 17411415

  • 1. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program.
    Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, Shore R, Hopkins S.
    AIDS Educ Prev; 2007 Apr; 19(2):124-36. PubMed ID: 17411415
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
    Leonard L, DeRubeis E, Pelude L, Medd E, Birkett N, Seto J.
    Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
    [Abstract] [Full Text] [Related]

  • 6. Methadone maintenance therapy outcomes in Iran.
    Noori R, Narenjiha H, Aghabakhshi H, Habibi G, Khoshkrood Mansoori B.
    Subst Use Misuse; 2012 Jun; 47(7):767-73. PubMed ID: 22416897
    [Abstract] [Full Text] [Related]

  • 7. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Avants SK, Margolin A, Usubiaga MH, Doebrick C.
    J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
    Larance B, Degenhardt L, Copeland J, Dillon P.
    Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
    Williams AB, McNelly EA, Williams AE, D'Aquila RT.
    AIDS Care; 1992 Nov; 4(1):35-41. PubMed ID: 1314099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
    Suntharasamai P, Martin M, Vanichseni S, van Griensven F, Mock PA, Pitisuttithum P, Tappero JW, Sangkum U, Kitayaporn D, Gurwith M, Choopanya K, Bangkok Vaccine Evaluation Group.
    Addiction; 2009 Feb; 104(2):235-42. PubMed ID: 19149819
    [Abstract] [Full Text] [Related]

  • 18. Reducing the risk of HIV infection associated with illicit drug use.
    American Academy of Pediatrics Committee on Pediatric AIDS.
    Pediatrics; 2006 Feb; 117(2):566-71. PubMed ID: 16452382
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey.
    Judson G, Bird R, O'Connor P, Bevin T, Loan R, Schroder M, McGrath R, Weatherall M, Moriarty H, Robinson G.
    Drug Alcohol Rev; 2010 Jan; 29(1):41-6. PubMed ID: 20078681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.